Ellina Tsymbal (MD)

Ellina Tsymbal (MD) has extensive work experience in the medical field. Ellina currently holds the position of Medical Director for UK, Ireland, and CEE at Otsuka Pharmaceutical Companies Europe since 2022. Prior to this, they served as the Medical Lead for UK and Ireland at Recordati from 2020 to 2022.

Ellina also worked as a Medical Advisor in the Diabetes division at Sanofi from 2017 to 2019, and previously held the role of Medical Advisor with multiple portfolios at Sanofi from 2013 to 2015.

Ellina gained valuable experience as an Intern at the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in 2016, where they focused on acute on chronic liver failure and the role of liver progenitor cells.

Before their career in the pharmaceutical industry, Ellina worked as a Medical Doctor at Gauteng Department of Health from 2007 to 2013.

Overall, Ellina Tsymbal has a diverse background in the medical field, with expertise in various roles and therapeutic areas.

Ellina Tsymbal (MD) has a diverse education history. Ellina pursued their medical education from 2001 to 2006 at the University of Pretoria/Universiteit van Pretoria, earning an MBChB degree in Medicine. In 2016 and 2017, Ellina attended the Universitat de Barcelona, where they obtained a Master's degree in Translational Medicine. Ellina'sacademic journey continued in 2019 at the IESE Business School, where they pursued an EMBA degree in Business Administration and Management, General. With these qualifications, Ellina Tsymbal has a strong foundation in both medical and business fields.